标普和纳斯达克内在价值 联系我们

Delta 9 Cannabis Inc. DLTNF OTC

Other OTC • Healthcare • Drug Manufacturers - Specialty & Generic • CA • USD

SharesGrow Score
14/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Delta 9 Cannabis Inc. (DLTNF) .

本页证实的标准:

  • VALUE (0/100, 未通过) — 综合估值评分低于60/100的通过门槛。

SharesGrow 综合评分: 14/100 其中 0/7 项标准通过。

SharesGrow 7-Criteria Score
14/100
SG Score
View full scorecard →
价值
N/A
No coverage
未來
N/A
No coverage
过去
0/100
→ Income
健康
0/100
Debt-to-Equity & liquidity
→ Health
护城河
14/100
→ Income
~
成长
48/100
→ Income
收入
10/100
→ Income

估值概览 — DLTNF

估值倍数
P/E (TTM)0.0
前瞻 P/EN/A
PEG 比率N/A
前瞻 PEGN/A
P/B 比率0.00
P/S 比率0.02
EV/EBITDA0.0
每股数据
EPS (TTM)$-0.10
每股账面价值$0.00
每股营收$0.40
每股自由现金流$0.00
收益率与内在价值
盈利收益率N/A
股息收益率0.00%

EPS:实际 vs 预期

P/E Ratio & Earnings Yield

每股收益 (EPS) 历史

Year EPS(稀释) 营收 净利润 净利润率
2014 $0.59 $0.00 $632.01K -
2015 $-0.14 $609.87K $-147.05K -24.1%
2016 $0.15 $498.33K $160.67K 32.2%
2017 $-0.16 $944.11K $-7.87M -833.7%
2018 $-0.10 $7.57M $-8.49M -112.1%
2019 $0.15 $31.77M $13.74M 43.3%
2020 $-0.06 $52.05M $-5.49M -10.5%
2021 $-0.11 $62.29M $-11.14M -17.9%
2022 $-0.22 $63.23M $-28.11M -44.5%
2023 $-0.10 $71.07M $-17.52M -24.6%
联系我们
🎓
SharesGrow 学院
学习如何计算内在价值,发现被低估的股票。
每周在线课程
给我们留言